Researchers have created a detailed molecular map showing exactly how influenza A virus takes over human cells, revealing an unexpected mechanism where the virus dissolves nuclear structures to free proteins needed for replication.
The discovery involves the virus's disruption of nuclear pore complexes, tiny structures that control what enters and exits a cell's nucleus. By breaking down these complexes, the flu virus releases nucleoporins, proteins that the virus appears to hijack for its own reproduction cycle. This hijacking strategy represents a previously underappreciated vulnerability in how the virus operates.
The research team identified dozens of cellular proteins and pathways that the flu virus manipulates during infection. By mapping these molecular interactions with precision, scientists can now pinpoint exactly where and how the virus depends on host cell machinery. This granular understanding opens pathways for developing new antiviral drugs that could block the virus at multiple steps in its lifecycle.
The work carries particular relevance for understanding dangerous flu variants like H5N1, which has recently spread to farm animals and humans in limited cases. H5N1 causes severe illness with high fatality rates, making it a pandemic concern. Understanding how the virus hijacks cells could help researchers design therapeutics specifically effective against this strain and future dangerous variants.
Current flu treatments like antivirals target specific viral proteins, but resistance emerges readily. By targeting the host cell machinery the virus needs, new drugs might present a harder target for the virus to circumvent. The approach shifts focus from attacking the pathogen directly to disrupting its dependence on the infected cell's normal functions.
The research also provides a framework for studying other viruses that similarly commandeer cellular machinery, potentially benefiting treatment development for related respiratory infections. Scientists can use this molecular map to screen for compounds that block the virus's access to essential host proteins without harming normal cell function.